IHR EHR Support SAMS

SOURCES SOUGHT SYNOPSIS

A Virtual Network to Investigate the Clinical Epidemiology of Influenza and the Effectiveness of Influenza Vaccines
Centers for Disease Control (CDC) is issuing this synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for a California-based integrated health care system to serve as an electronic health record site in CDC’s VISION 2.0 respiratory pathogen surveillance network, providing integrated, longitudinal medical, laboratory, pharmacy, vaccination, claims, and outcomes data to support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research across emergency/urgent care, inpatient, and intensive care unit (ICU) settings. The result of this market research will contribute to determining the method of acquisition. The applicable North American Industry Classification System (NAICS) code assigned to this acquisition is 541380- Testing Laboratories and Services.
DISCLAIMER: The government intends to release a solicitiation in the near future; however, this notice is issued for market research and planning purposes only and does not constitute a solicitation or commitment by the Government. All information submitted is voluntary and no award will be made as a result of this notice. The Government will not reimburse any costs incurred in responding. No proprietary or sensitive information should be included in the capability statement.
If your organization has the potential capacity to perform these contract services, please provide the following information:
1) organization name, address, email address, website address, telephone number, and size and type of ownership for the organization; and
2) tailored capability statements addressing the requirements of this effort, with supporting documentation substantiating the organizations and proposed staff’s capabilities. If significant subcontracting or teaming is anticipated, respondents shall describe the proposed administrative, technical, and management structure, including the roles and responsibilities of each organization.
The capability statement shall demonstrate the respondent’s ability to maintain and provide access to integrated, high-quality, longitudinal medical, laboratory, pharmacy, vaccination, claims, and immunization-registry data. The data must support identification of acute respiratory illness encounters and laboratory-confirmed influenza among patients of all